SCHEMBL6720356

SCHEMBL6720356

CCOC(=O)c1nsc2cc(F)c(N)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
MAPT P10636 7/20 0.41
KDM4E B2RXH2 5/20 0.41
HPGD P15428 5/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MAPK1 P28482 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
HSD17B10 Q99714 4/20 0.39
GAA P10253 3/20 0.39
TSHR P16473 2/20 0.39
GLA P06280 1/20 0.39
ALOX15 P16050 1/20 0.37
PRKCZ Q05513 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6717492 0.78 SMN1; SMN2 (0.38) ALDH1A1MAPTKDM4EHPGDNPC1
SCHEMBL492210 0.74 CA12 (0.48) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL8226360 0.74 IDO1 (0.43) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL492013 0.73 ELANE (0.49) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL1635139 0.73 ELANE (0.49) ALDH1A1MAPTKDM4ENPC1RAB9A
SCHEMBL492326 0.72 KDM4E (0.52) ALDH1A1MAPTKDM4EHPGDNPC1
SCHEMBL6591576 0.72 TLR4 (0.30) ALDH1A1
SCHEMBL1176572 0.72 TP53 (0.67) MAPTKDM4EMAPK1SMN1; SMN2TP53
SCHEMBL2596428 0.69 ALDH1A1 (0.53) ALDH1A1MAPTKDM4EHPGDNPC1
SCHEMBL21723240 0.68 ALDH1A1 (0.51) ALDH1A1MAPTKDM4EHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097728-A1 Method for producing anellated tetrahydro-{1h}-triazoles BASF AKTIENGESELLSCHAFT (DE) 2004-05-20 US disclosed
EP-1196399-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED BENZISOTHIAZOLE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2002-04-17 EP disclosed
WO-2001005775-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED BENZISOTHIAZOLE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2001-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097728-A1 Method for producing anellated tetrahydro-{1h}-triazoles CBR1, CBR3, QSOX1 ALDH1A1 709/4885MAPT 4497/4885KDM4E 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.